Sensei Biotherapeutics, Inc. (SNSE)

Sensei Biotherapeutics Statistics

Total Valuation

SNSE has a market cap or net worth of $10.56 million. The enterprise value is -$20.56 million.

Market Cap	10.56M
Enterprise Value	-20.56M

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025, before market open.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

SNSE has 1.26 million shares outstanding. The number of shares has decreased by -5.08% in one year.

Current Share Class	1.26M
Shares Outstanding	1.26M
Shares Change (YoY)	-5.08%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	2.30%
Owned by Institutions (%)	7.72%
Float	827,412

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.33
P/TBV Ratio	0.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.82, with a Debt / Equity ratio of 0.10.

Current Ratio	6.82
Quick Ratio	6.57
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-393.43

Financial Efficiency

Return on equity (ROE) is -64.18% and return on invested capital (ROIC) is -37.14%.

Return on Equity (ROE)	-64.18%
Return on Assets (ROA)	-35.14%
Return on Invested Capital (ROIC)	-37.14%
Return on Capital Employed (ROCE)	-89.30%
Revenue Per Employee	n/a
Profits Per Employee	-$1.94M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.52% in the last 52 weeks. The beta is 0.09, so SNSE's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	-42.52%
50-Day Moving Average	7.23
200-Day Moving Average	9.04
Relative Strength Index (RSI)	63.88
Average Volume (20 Days)	12,130

Short Selling Information

The latest short interest is 90,363, so 7.17% of the outstanding shares have been sold short.

Short Interest	90,363
Short Previous Month	69,706
Short % of Shares Out	7.17%
Short % of Float	10.92%
Short Ratio (days to cover)	0.52

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.51M
Pretax Income	-29.67M
Net Income	-29.03M
EBITDA	-28.48M
EBIT	-29.51M
Earnings Per Share (EPS)	-$23.08

Balance Sheet

The company has $34.33 million in cash and $3.21 million in debt, giving a net cash position of $31.12 million or $24.69 per share.

Cash & Cash Equivalents	34.33M
Total Debt	3.21M
Net Cash	31.12M
Net Cash Per Share	$24.69
Equity (Book Value)	31.99M
Book Value Per Share	25.38
Working Capital	30.45M

Cash Flow

In the last 12 months, operating cash flow was -$24.15 million and capital expenditures -$109,000, giving a free cash flow of -$24.26 million.

Operating Cash Flow	-24.15M
Capital Expenditures	-109,000
Free Cash Flow	-24.26M
FCF Per Share	-$19.25

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SNSE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	5.08%
Shareholder Yield	5.08%
Earnings Yield	-274.84%
FCF Yield	-229.66%

Analyst Forecast

The average price target for SNSE is $86.67, which is 934.25% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$86.67
Price Target Difference	934.25%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-51.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 17, 2025. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Jun 17, 2025
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1